R Squared LTD Galapagos Nv Transaction History
R Squared LTD
- $93.6 Billion
- Q1 2025
Shares
1 transactions
Others Institutions Holding GLPG
# of Institutions
91Shares Held
11.6MCall Options Held
216KPut Options Held
313K-
Tang Capital Management LLC San Diego, CA3.96MShares$106 Million6.46% of portfolio
-
Bvf Inc San Francisco, CA1.45MShares$39.1 Million1.61% of portfolio
-
Prosight Management, LP Dallas, TX1.31MShares$35.3 Million11.76% of portfolio
-
Deep Track Capital, LP Greenwich, CT741KShares$19.9 Million0.65% of portfolio
-
Finepoint Capital LP Boston, MA657KShares$17.6 Million1.74% of portfolio
About GALAPAGOS NV
- Ticker GLPG
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,835,500
- Market Cap $1.77B
- Description
- Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...